Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorLakeman, Inge
dc.contributor.authorvan den Broek, Alexandra J.
dc.contributor.authorVos, Juliën A. M.
dc.contributor.authorBarnes, Daniel
dc.contributor.authorAdlard, Julian
dc.contributor.authorandrulis, irene
dc.contributor.authorBalmaña, Judith
dc.date.accessioned2022-02-25T13:41:35Z
dc.date.available2022-02-25T13:41:35Z
dc.date.issued2021-09
dc.identifier.citationLakeman IMM, van den Broek AJ, Vos JAM, Barnes DR, Adlard J, Andrulis IL, et al. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. Genet Med. 2021 Sep;23(9):1726–37.
dc.identifier.issn1530-0366
dc.identifier.urihttps://hdl.handle.net/11351/7091
dc.descriptionPredicció de risc de càncer de mama; Dones europees; Variant patògena heterozigota
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.ispartofseriesGenetics in Medicine;23(9)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMama - Càncer - Diagnòstic
dc.subjectMalalties congènites
dc.subjectDiàtesi
dc.subject.meshBreast Neoplasms
dc.subject.mesh/diagnosis
dc.subject.meshGenetic Predisposition to Disease
dc.titleThe predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s41436-021-01198-7
dc.subject.decsneoplasias de la mama
dc.subject.decs/diagnóstico
dc.subject.decspredisposición genética a la enfermedad
dc.relation.publishversionhttps://doi.org/10.1038/s41436-021-01198-7
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Lakeman IMM] Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. [van den Broek AJ, Vos JAM] Division of Molecular Pathology, The Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. [Barnes DR] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [Adlard J] Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK. [Andrulis IL] Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada. Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. [Balmaña J] Hereditary cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid34113011
dc.identifier.wos000659837100010
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple